Search

Your search keyword '"Aiuti Alessandro"' showing total 1,371 results

Search Constraints

Start Over You searched for: Author "Aiuti Alessandro" Remove constraint Author: "Aiuti Alessandro"
1,371 results on '"Aiuti Alessandro"'

Search Results

1. A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID

2. Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

4. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

5. Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency

6. A GLB1 transgene with enhanced therapeutic potential for the preclinical development of ex-vivo gene therapy to treat mucopolysaccharidosis type IVB

8. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

9. Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survival

10. Hematopoietic reconstitution dynamics of mobilized- and bone marrow-derived human hematopoietic stem cells after gene therapy

11. Circulating hematopoietic stem/progenitor cell subsets contribute to human hematopoietic homeostasis

12. Early bone marrow alterations in patients with adenosine deaminase 2 deficiency across disease phenotypes and severities

13. Genetic determinants of type 1 diabetes in individuals with weak evidence of islet autoimmunity at disease onset

14. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

15. Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity

16. Coronavirus disease 2019 in patients with inborn errors of immunity: An international study

17. Molecular purging of multiple myeloma cells by ex-vivo culture and retroviral transduction of mobilized-blood CD34+ cells

19. Gene therapy for Wiskott-Aldrich syndrome: History, new vectors, future directions

21. A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease

22. Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress

25. The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet)

26. Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency.

27. Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study

29. Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis

31. Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access

33. Autonomous role of Wiskott-Aldrich syndrome platelet deficiency in inducing autoimmunity and inflammation

34. Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study.

35. From Your Nose to Your Toes: A Review of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic‒Associated Pernio

36. 16 Bone marrow damage in patients with Adenosine Deaminase 2 Deficiency

37. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations

38. Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency

39. Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders

40. Interleukin-1 blockade in patients with Wiskott-Aldrich syndrome: a retrospective multinational case series

41. Retrieval of vector integration sites from cell-free DNA

42. Adolescent gender dysphoria management: position paper from the Italian Academy of Pediatrics, the Italian Society of Pediatrics, the Italian Society for Pediatric Endocrinology and Diabetes, the Italian Society of Adolescent Medicine and the Italian Society of Child and Adolescent Neuropsychiatry

43. Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survival

44. Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome

45. Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survival

48. Treatment with rapamycin can restore regulatory T-cell function in IPEX patients

49. Reduced PD-1 expression on circulating follicular and conventional FOXP3+ Treg cells in children with new onset type 1 diabetes and autoantibody-positive at-risk children

50. Atidarsagene autotemcel (autologous hematopoietic stem cell gene therapy) preserves cognitive and motor development in early-onset metachromatic leukodystrophy with up to 12 years follow-up

Catalog

Books, media, physical & digital resources